Delivery Order SPE2DB22D9353-SPE2DB25FX2DY
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,347.34 by the Defense Logistics Agency on July 31, 2025, for the supply of Nplate 250 microgram vials. The delivery order carries an ultimate completion date of August 21, 2025, and requires performance at the contractor's Park Ridge, Illinois facility. This award was issued without a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,694.68 by the Defense Logistics Agency on July 29, 2025, for the supply of Nplate 250 microgram vials. The award carries an ultimate completion date of August 19, 2025, and was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $6,697.06 to DMS Pharmaceutical Group Inc. for the supply of Nplate 500 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform work at its Park Ridge facility with an ultimate completion date of August 14, 2025. This delivery order utilizes a firm fixed-price contract type with no set-aside designation, allowing the company to compete on a...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 250 microgram vials of Nplate, valued at $8,368.35, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform the work at its Park Ridge location and deliver the pharmaceutical product to support federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,681.63 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its location in Park...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,389.36 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its facility in Park Ridge, IL, with an ultimate completion date of August 11, 2025. The award was issued on July 21, 2025, and does not include a set-aside designation, allowing the...
- The Defense Logistics Agency awarded a delivery order valued at $1,673.67 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a pharmaceutical supply requirement to support Department of Defense healthcare operations. The award was made without a set-aside designation, and the products will be delivered to Park Ridge, Illinois, where the...
- The Defense Logistics Agency awarded a $6,697.06 delivery order to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Nplate 500 microgram vials, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply fulfillment for federal healthcare needs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NPLATE 250 MCG VIALS. The contract, valued at $10,167.36, has an ultimate completion date of June 20, 2024 and was awarded on May 29, 2024. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to the U.S. federal...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2DYDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,366.20 by the Defense Logistics Agency on September 2, 2025, for the supply of Nplate 125 microgram vials. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The contract carries no set-aside designation, and performance is scheduled for completion by September 23, 2025, at the contractor's facility in Park Ridge, Illinois. Nplate is a specialty pharmaceutical used to treat thrombocytopenia, a condition characterized by low platelet counts, making this delivery order part of the DLA's broader pharmaceutical supply chain supporting military healthcare facilities nationwide. As a critical supplier within the federal pharmaceutical distribution network, DMS Pharmaceutical Group leverages its established IDC vehicle to provide direct delivery of prescription drugs and medical consumables to Department of Defense healthcare sites, complementing its extensive portfolio of branded and generic medications, biologics, and specialty treatments serving military medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/2/25 |